ODN 2216-Type A (human, Biotin Conjugate) (VAdv-Ly0047)

CAT Size Price Quantity
VAdv-Ly0047

ODN 2216-Type A, human TLR9 agonist, biotin conjugate, oligodeoxy nucleotide vaccine adjuvant.

Specifications
Type
CpG
Specificity
TLR9 agonist
Product Form
Powder
Percentage
≥ 95%
Endotoxin
Lower than 2 EU/mg.
Storage
Store at -20°C.
Shelf Life
1 year.
Adjuvant Information
Introduction
ODN 2216 is a type A huamn TLR9 agonist. CpG ODNs 2216 can induce strong Th1-like immune activation, with the secretion of type-I cytokine and activation of strong CD8+ T-cell responses. PBMNCs activated by CpG ODNs can more strongly kill k562 cells in vitro.
Sequence
5'-ggGGGACGATCGTCgggggg-biotin' (20 mer)
Related Product

All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.


Online Inquiry

All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Project Description:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CONTACT US

USA

Tel:
Fax:
Email:
UK

Tel:
Email:
Germany

Tel:
Email:


Follow us on

Shopping Basket